Small-molecule based therapy for Metastatic tumors: Celastrol suppresses the expression of PD-1 , a suppressor of activation of T-cells, via down regulation of its target gene, 16/February/2015, 23.18

Small-molecule based therapy for Metastatic tumors: Celastrol suppresses the expression of PD-1 , a suppressor of activation of T-cells, via down regulation of its target gene, 16/February/2015, 23.18

Small-molecule based therapy for Metastatic tumors: Celastrol suppresses the expression of PD-1 , a suppressor of activation of T-cells, via down regulation of its target gene, 16/February/2015, 23.18 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Small-molecule based therapy for Metastatic tumors: Celastrol suppresses the expression of PD-1 , a suppressor of activation of T-cells, via down regulation of its target gene, 16/February/2015, 23.18, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests that Celastrol, by suppressing the expression of its target gene, it may decrease the expression of PD-1.  Thereby, it may activate the immune system that attack tumors and inhibit tumor progression. Thus, pharmacological formulations encompassing “Celastrol or its analogues  may be used to inhibit the progression of tumors.

Amount: $ 500*

Undisclosed information: How Celastrol suppresses the expression of PD-1

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org